ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

26,71
6,49
( 32,10% )
Mis à jour : 17:03:24

Tango Therapeutics Inc (TNGX) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
26,71
( 32,10% )
Prix Achat
26,67
Prix Vente
26,71
Volume échangé
9 646 026
26,08 Fourchette du Jour 30,01
3,77 Plage de 52 semaines 30,01
Cap du marché
Clôture Veille
20,22
Ouverture
30,005
Dernière Transaction
50
@
26.69
Dernière heure de transaction
17:03:24
Volume financier
US$ 262 579 422
VWAP
27,2215
Volume moyen (3 m)
US$ 3 346 420
Actions en circulation
144 647 982
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-24,92
Bénéfice par action (BPA)
-0,86
Chiffre d'affairess (LTM)
56,99M
Bénéfice net (LTM)
-107,23M

À propos de Tango Therapeutics Inc

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is ... Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Boston, United States
Fondé
2026
Tango Therapeutics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker TNGX. Le dernier cours de clôture d'Tango Therapeutics était de US$20,22. Au cours de la dernière année, les actions de Tango Therapeutics ont été négociées dans une fourchette de prix de US$ 3,77 à US$ 30,01.

Tango Therapeutics compte actuellement 144 647 982 actions en circulation. La capitalisation boursière d'Tango Therapeutics est de US$3,86 milliard. Tango Therapeutics a un ratio cours/bénéfice (ratio PE) de -24.92.

Flux d'options Tango Therapeutics (TNGX)

Flux global

Baissier

Prime nette

-74k

Calls / Puts

0.00%

Ach. / Vent.

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

TNGX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
14.9522.748161764721.7630.0119.4275258556321.55122728CS
43.5115.129310344823.230.0119.342287535621.72003914CS
129.3854.125793421817.3330.0117.25301070622.04320458CS
2616.92172.8294177739.7930.018.3313250716.67131273CS
5222.26500.2247191014.4530.013.77289592612.31435971CS
15623.02623.8482384823.6930.011.0317875279.44131674CS
26017.1177.9396462029.6130.011.0311984569.26925933CS

TNGX - Frequently Asked Questions (FAQ)

What is the current Tango Therapeutics Inc share price?
The current share price of Tango Therapeutics Inc is US$ 26,71
How many Tango Therapeutics Inc shares are in issue?
Tango Therapeutics Inc has 144 647 982 shares in issue
What is the market cap of Tango Therapeutics Inc?
The market capitalisation of Tango Therapeutics Inc is USD 3,86B
What is the 1 year trading range for Tango Therapeutics Inc share price?
Tango Therapeutics Inc has traded in the range of US$ 3,77 to US$ 30,01 during the past year
What is the PE ratio of Tango Therapeutics Inc?
The price to earnings ratio of Tango Therapeutics Inc is -24,92
What is the cash to sales ratio of Tango Therapeutics Inc?
The cash to sales ratio of Tango Therapeutics Inc is 54,49
What is the registered address of Tango Therapeutics Inc?
The registered address for Tango Therapeutics Inc is 201 Brookline Avenue, Boston, Massachusetts, 02215
What is the Tango Therapeutics Inc website address?
The website address for Tango Therapeutics Inc is www.tangotx.com
Which industry sector does Tango Therapeutics Inc operate in?
Tango Therapeutics Inc operates in the Biotechnology & Life Sciences sector

TNGX Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock